Medication info
Atorva Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Atorva Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›20.73mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200705991 · Notified 2007.05.25 · Insurance code 642100990

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult population.
Child dose
Ages 10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted appropriately for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • vascular interventions
  • stable angina pectoris
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina pectoris
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It is particularly effective in adults with risk factors for coronary heart disease or type 2 diabetes, reducing the risk of myocardial infarction and stroke. Moreover, in patients already diagnosed with heart disease, it lowers the risk of hospitalization due to myocardial infarction, stroke, angina, vascular interventions, and congestive heart failure. It is also used for the treatment of hyperlipidemia, effectively reducing total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL cholesterol levels as an adjunct to dietary therapy. It is especially beneficial in patients with familial hypercholesterolemia and pediatric patients. This medication effectively improves cardiovascular diseases and hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It may be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult population.

Child dose

Ages 10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted appropriately for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related symptoms, and patients should immediately inform their doctor if they experience muscle pain, weakness, or cramps. If there is a significant increase in creatine kinase (CK) levels in blood tests, this medication should be discontinued. It should not be used in patients with active liver disease or severely impaired liver function, in those with muscle disorders, during pregnancy or in women who might become pregnant, and in children under the age of 10. Caution is advised for patients with a history of alcohol abuse or liver disease, impaired kidney function, hypothyroidism, elderly patients, who should undergo regular blood tests. This medication can affect liver function; if symptoms of hepatitis or jaundice, nausea, vomiting, or fatigue occur, medical attention should be sought immediately. Furthermore, it should not be used in pregnant or nursing women, and fertile women should use appropriate contraception while taking this medication. This medication may interact with other drugs; therefore, it's essential to inform the doctor or pharmacist of any medications currently being taken. Special caution is required when taken with certain antibiotics, antifungals, antivirals, immunosuppressants, and some blood pressure medications. In case of overdose, there are no specific antidotes, so treatment should be symptomatic and liver function and muscle status must be closely monitored. Lastly, keep this medication out of the reach of children and store it in its original container to prevent deterioration or misuse.

Side effects

  • Fatigue
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • anorexia
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • oropharyngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • perception disorders
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated CK levels
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • acute postprandial hypoglycemia
  • bronchitis
  • rhinitis
  • pneumonia
  • respiratory distress
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitive reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • anxiety
  • muscle inflammation
  • myopathy
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency incontinence
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypoglycemia
  • increased appetite
  • vascular neurogenic edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • auditory loss
  • glaucoma
  • colored vision
  • taste loss
  • taste disturbance
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it must be stored in a tightly closed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.